|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
A binomial logistic regression was performed to evaluate Ranson's criteria and IL6, IL8, and IL10 (at admission and after 48 hours) in the course of AP.
|
31242405 |
2020 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serum IL-10 increased uniformly in AP, without any effect of preceding VR or VL.
|
30690339 |
2019 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We investigate the dynamic longitudinal changes in circulating IL-10-producing B cells (B10) and memory CD19<sup>+</sup>CD24<sup>hi</sup>CD27<sup>hi</sup> cells in patients with AP to evaluate their prediction utility for AP severity.
|
30546828 |
2018 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
IL-10 gene rs1800896 polymorphism increases the risk of AP.
|
29310417 |
2017 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
MS treatment reversed the increased serum level of amylase and lipase, alleviated the pathological damage in the pancreas, and decreased the expression of TNFα, IL-6, IFNγ and IL-10 in cerulean-induced AP mice.
|
28759809 |
2017 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, this study demonstrates that the IL-10 -1082A/G gene polymorphism contributes to the development of acute pancreatitis.
|
27173345 |
2016 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, IL-10 rs1800896 was correlated with an increased risk of acute pancreatitis in codominant, dominant, and recessive models.
|
26634555 |
2015 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we suggest that IL-10-1082A/G gene polymorphisms contribute to the development of acute pancreatitis in codominant, dominant and recessive models.
|
26823862 |
2015 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
After 7 days the serum concentrations of IL-10 were higher in the EA group than in the control group (mild AP: 6.2±1.2 vs 5.2±0.9 pg/mL, p<0.05; severe AP: 14.9±7.8 vs 7.9±6.3 pg/mL, p<0.05).
|
25520280 |
2015 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We found that the IL-8 -251T/A polymorphism is associated with an increased risk of acute pancreatitis, and no significant association between IL-1βand IL-10 gene polymorphisms and risk of acute pancreatitis was detected.
|
26125871 |
2015 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, we found no significant association between IL-1β +3954 C/T, IL-1β -511 C/T, IL-6 -174 G/C, IL-6 -174 G/C, IL-6 -634 C/G, IL-10 -1082A/G, or IL-10 -819C/T polymorphisms and risk of acute pancreatitis.
|
25730090 |
2015 |
|
Acute pancreatitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, there were no significant associations between IL-1β (IL-1β +3954 C/T (rs1143634) and IL-1β -511 C/T (rs16944)), IL-6 (IL-6 -174 G/C (rs1800795) and IL-6 -634 C/G (rs1800796)) and IL-10 (IL-10 -1082 A/G (rs1800896), IL-10 -819 C/T (rs1800871) and IL-10 -592 C/A (rs1800872)) gene polymorphisms and AP risk.
|
24072654 |
2013 |
|
Acute pancreatitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tumor necrosis factor-α and interleukin-10 contribute to immunoparalysis in patients with acute pancreatitis.
|
20937337 |
2011 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This article investigates the relationship between different polymorphisms of tumor necrosis factor alpha (TNF-alpha), interleukin 1 (IL-1), IL-1 receptor antagonist, IL-6, and IL-10 with the severity and etiology of AP and the serum levels of the cytokine encoded.
|
18815552 |
2008 |
|
Acute pancreatitis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The purpose of this study was to evaluate the ability to transfect a murine pancreas with a human cytokine regulatory gene (interleukin-10 [IL-10]) and examine the duration of transgene expression, its effect on the normal pancreas, and its antiinflammatory effect during acute pancreatitis.
|
9637544 |
1998 |